" class="no-js "lang="en-US"> Apollo Therapeutics - Medtech Alert
Sunday, February 05, 2023

Breaking News

Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest enGene Appoints Alex Nichols, PhD as President and Chief Operating Officer Orexo Submits New Drug Application to FDA for OX124, a High-dose Rescue Medication for Opioid Overdose Abbott Announces US and European Approvals for New Technologies to Support Effective Treatment for Abnormal Heart Rhythms RefleXion Receives FDA Clearance for Biology-Guided Radiotherapy Treatment for Early and Late-stage Cancers Cardiff Oncology Announces the Appointment of Fairooz Kabbinavar, MD, FACP, as Chief Medical Officer
Apollo Therapeutics | Pharmtech Focus

Apollo Therapeutics

About Apollo Therapeutics

Apollo Therapeutics

Related Story

Fundraising

 Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development | Pharmtech Focus

Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development

June 18 2021

Apollo Therapeutics, a portfolio-based biopharmaceutical company rapidly advancing potentially transformative treatments based on breakthrough discoveries, […]